February 2025 in “International Journal of Dermatology” In this review, researchers examined pressure alopecia related to injectable treatments, identifying that injected volume can compress blood vessels, leading to hair loss through ischemia and inflammation, which emphasizes the need for targeted risk management and therapeutic strategies in dermatology.
September 2023 in “Journal of the American Academy of Dermatology” In their commentary, the authors introduce additional cosmetic procedures—thread lifts, temporal lifting with dermal fillers, and facelifts—that may lead to type 2 pressure alopecia, expanding the understanding of this condition's potential causes beyond the original classification tied to cosmetic injections and sustained external pressure.
1 citations
,
July 2023 in “Journal of the American Academy of Dermatology” This review reports that pressure-induced alopecias, occurring from ischemic pressure, are often reversible without treatment if diagnosed promptly, but prognosis varies with severity and treatment timing.
November 2023 in “International Journal of Dermatology” In this study, CCCA patients were found to have higher odds of metabolic, autoimmune, atopic, and psychiatric comorbidities compared to matched controls.
89 citations
,
March 2001 in “Endocrine practice” This article provides diagnosis and treatment guidelines for hyperandrogenic disorders in women but reports no new clinical results; it offers a summary of accepted scientific information and suggestions for clinical practice.